Table 1.
Parameters | Total | Female Patients | Male Patients | p * |
---|---|---|---|---|
Demografics | ||||
N | 570 | 304 | 266 | |
Age (years) | 65.0 (53.0–74.0) | 64.0 (50.0–75.0) | 65 (55.3–73.0) | p = 0.498 |
Height (cm) | 167.0 (160.0–172.0) | 161.0 (156.0–165.0) | 172.0 (168.0–178.0) | p < 0.001 |
Weight (kg) | 70.0 (60.0–81.1) | 63.1 (55.0–74.0) | 75.0 (68.0–86.0) | p < 0.001 |
Loss Weight (%) | 2.12 (0.0–8.51) | 0.9 (0.0–8.1) | 3.2 (0.0–8.6) | p = 0.015 |
BMI (kg/H2) | 24.9 (22.0–28.1) | 24.2 (21.4–27.5) | 25.6 (23.2–28.5) | p = 0.001 |
Nutritional Tools | ||||
SGA | p = 0.114 | |||
A | 241 (42.3%) | 118 (38.8%) | 123 (46.2%) | |
B | 204 (35.8%) | 116 (38.2%) | 88 (33.1%) | |
C | 125 (21.9%) | 70 (23%) | 55 (20.7%) | |
MUST | p = 0.656 | |||
0 | 263 (46.1%) | 136 (44.7%) | 127 (48.3%) | |
1 | 123 (21.6%) | 70 (23.0%) | 51 (42.9%) | |
2 | 184 (32.3%) | 98 (32.3%) | 86 (46.8%) | |
BIVA | ||||
PhA (°) | 5.1 (4.1–6.1) | 4.9 (3.98–5.8) | 5.45 (4.3–6.57) | p < 0.001 |
SPhA | 1.97 (−1.5–1.1) | 0.0 (−1.1–1.42) | −0.4 (−1.9–0.77) | p < 0.001 |
BCM (kg) | 23.6 (18.7–29.6) | 20.4 (16.9–24.4) | 29.2 (22.7–35.1) | p < 0.001 |
Functional test | ||||
HGS (kg) | 26.0 (19.0–35.0) | 20.0 (17.0–25.8) | 35.0 (27.0–40.0) | p < 0.001 |
Outcomes | ||||
Long stay (days) | 7.0 (3.0–12.3) | 7.0 (7.0–12.0) | 7.0 (7.0–14.0) | p = 0.871 |
Death, n (%) | 86 (15.1%) | 42.0 (13.8%) | 44.0 (16.5%) | p = 0.450 |
* p for comparison by gender patients. BMI body mass index; H: height; MUST (Malnutrition Universal Screening tool). Subjective Global Assessment (SGA); PhA: phase angle; SPhA: standardized phase angle; BCM: body cell mass, HGS: handgrip strength.